Asunto(s)
Dengue , Viaje , Humanos , Ecuador , Colombia , Dengue/diagnóstico , Masculino , Púrpura/etiología , Adulto , Enfermedades Transmisibles Importadas/diagnóstico , FemeninoRESUMEN
BACKGROUND Cutaneous adverse drug reactions are the skin's response to a systemic exposure to drugs. Linezolid is an oral oxazolidine used to treat methicillin-resistant Staphylococcus aureus infections. Even though it has well-known adverse effects, purpuric cutaneous adverse drug reactions to linezolid have been scarcely described. This report is of a Puerto Rican man in his 80s who developed an extensive purpuric drug eruption secondary to linezolid use. Clinicians should be aware of this phenomenon, since prompt identification and discontinuation of the agent are essential for recovery. CASE REPORT An 89-year-old Puerto Rican man was given oral linezolid therapy for healthcare-associated pneumonia and developed a widespread, purpuric cutaneous eruption 5 days into therapy. His condition prompted immediate discontinuation of the drug. Forty-eight hours after stopping the medication, he visited the Emergency Department. Abdominal punch biopsy revealed a superficial and perivascular lymphocytic infiltrate with dermal eosinophils, a pathologic finding consistent with a purpuric drug eruption. This allowed for a timely diagnosis, exclusion of other mimickers, such as cutaneous vasculitis, and effective management. CONCLUSIONS Cutaneous adverse drug reactions to linezolid have been scarcely reported in the literature. Due to the low incidence of this manifestation, the identification of the causative agent and accompanying treatment may be delayed. Mainstays in therapy are avoidance of the offending agent and treatment with corticosteroids, antihistamines, barrier ointments, and oral analgesics. Primary healthcare providers should be aware of linezolid-induced cutaneous manifestations, diagnostic clues, and treatment options so they can rapidly identify and effectively treat such complications.
Asunto(s)
Erupciones por Medicamentos , Exantema , Staphylococcus aureus Resistente a Meticilina , Púrpura , Vasculitis , Masculino , Humanos , Anciano de 80 o más Años , Linezolid/efectos adversos , Púrpura/inducido químicamente , Púrpura/complicaciones , Púrpura/patología , Erupciones por Medicamentos/diagnóstico , Erupciones por Medicamentos/etiología , Erupciones por Medicamentos/patología , Vasculitis/complicacionesRESUMEN
A dermatoporose é a síndrome de fragilidade cutânea. Acomete principalmente indivíduos acima de 60 anos, com maior prevalência no sexo feminino. Os principais fatores de risco são: envelhecimento, exposição solar intensa e uso de corticoterapia tópica e sistêmica. Se manifesta clinicamente por atrofia cutânea, púrpuras senis, pseudo cicatrizes estrelares e lacerações, podendo evoluir com hematomas dissecantes e infecções graves. Trata-se de uma doença com grande impacto na qualidade de vida dos pacientes e, até o presente momento, não há terapias com resultados satisfatórios. Hidratação, vitamina C tópica e oral, luz intensa pulsada foram algumas das terapêuticas estudadas. A hidroxiapatita de cálcio é um bioestimulador de colágeno composto por microesferas em um veículo de carboximetilcelulose (Radiesse®). Tem sido usada para estimular a produção endógena de colágeno e consequentemente melhorar a qualidade e espessura da pele. Este efeito do produto poderia melhorar o quadro clínico da dermatoporose. O estudo teve como objetivo avaliar a melhora das lesões purpúricas e da atrofia da pele após aplicação de Radiesse® no antebraço de 5 pacientes portadores de dermatoporose no setor de Dermatologia do Hospital do Servidor Público Municipal de São Paulo. Os 5 pacientes foram submetidos a aplicação de Radiesse® nos antebraços e foram avaliadas 45 e 90 dias após o procedimento, o número de lesões purpúricas, grau de atrofia da pele através do teste de pinçamento e realizado comparação fotográfica. Após o tratamento, observou-se melhora do número das lesões purpúricas, melhora da atrofia da pele e melhora da qualidade de pele quando comparada fotograficamente. Dessa forma, o tratamento com Radiesse® mostrou-se promissor, com resultados satisfatórios e com um bom perfil de segurança. Palavras-chave: Dermatoporose. Púrpura senil. Radiesse. Bioestimulador. Tratamento.
Asunto(s)
Púrpura/tratamiento farmacológico , Atrofia/diagnóstico , Piel/efectos de los fármacos , Enfermedades de la Piel/diagnóstico , Envejecimiento/efectos de los fármacos , Carboximetilcelulosa de Sodio/administración & dosificación , Envejecimiento de la Piel/efectos de los fármacos , Corticoesteroides/efectos adversos , Deshidroepiandrosterona/fisiología , Durapatita/administración & dosificación , Durapatita/uso terapéutico , Terapia por Luz de Baja IntensidadRESUMEN
Fig. 1- Se observa exantema cutáneo morbiliforme a forma de múltiples lesiones maculares blanquecinas, redondas, confluentes de piel respetada y de diámetro variable, asociadas a petequias diseminadas dando el aspecto de islas blancas en un mar rojo
Asunto(s)
Humanos , Púrpura/etiología , Dengue/epidemiología , Exantema/etiologíaRESUMEN
We present the case of a 32-year-old male, previously healthy, with a 5-day history of fever, frontal-occipital headache, retro-ocular pain, rash, petechiae, myalgia, arthralgia, and abdominal pain. Blood tests with leukopenia, severe thrombocytopenia, transaminitis, long clotting times. Severe dengue with associated coagulopathy was diagnosed, indicating transfer to ICU. Presents torpid evolution, altered state of consciousness, psychomotor agitation, and aggressiveness. Structural, ischemic-hemorrhagic alterations, bacterial and fungal infections were ruled out. Finally diagnosing dengue encephalitis, confirmed by DENV PCR in CSF. Support measures are provided with favorable evolution. Encephalitis is the most serious neurological complication after dengue virus infection.
Asunto(s)
Dengue , Encefalitis , Púrpura , Dengue Grave , Trombocitopenia , Adulto , Dengue/complicaciones , Dengue/diagnóstico , Encefalitis/complicaciones , Fiebre , Humanos , Masculino , Dengue Grave/complicaciones , Dengue Grave/diagnósticoRESUMEN
Parvovirus B19 is the cause of a variety of exanthematous diseases during childhood and adolescence, such as erythema infectiosum and papular purpuric gloves and socks syndrome. This is an unusual, benign and acute acrodermatitis. Aphtous stomatitis, fever and other systemic symptoms can be associated with the eruption of the purpuric rash. Uncommon patterns such as asymmetrical distribution or erythematous involvement llave recently been described as additional features of PVB19-associated purpuric petechial eruption. This is a case report of a 12-year-old female with an atypical involvement of a papular-purpuric syndrome caused by human parvovirus B19.
Asunto(s)
Eritema Infeccioso , Dermatosis del Pie , Parvovirus B19 Humano , Púrpura , Adolescente , Niño , Eritema Infeccioso/complicaciones , Eritema Infeccioso/diagnóstico , Femenino , Dermatosis del Pie/complicaciones , Humanos , Púrpura/etiología , SíndromeRESUMEN
Resumen Se presenta el caso de un varón de 32 años, previamente sano, que consultó por fiebre de cinco días, cefalea, dolor retro-ocular, rash, petequias, mialgias, artralgias y dolor abdominal. Presentaba leucopenia, trombocitopenia intensa, transaminitis y tiempo de coagulación prolongado. Se diagnosticó un dengue grave con coagulopatía que requirió manejo en Unidad de Cuidados Intensivos. Evolucionó con alteración del estado de conciencia, agitación psicomotora y agresividad. Se descartaron alteraciones estructurales, isquémicohemorrágicas, infecciones bacterianas y micóticas. Se confirmó finalmente una encefalitis por dengue por una RPC para virus dengue positiva en LCR. Se brindaron medidas de soporte con una evolución favorable. La encefalitis es la complicación neurológica más grave tras la infección por virus del dengue.
Abstract We present the case of a 32-year-old male, previously healthy, with a 5-day history of fever, frontal-occipital headache, retro-ocular pain, rash, petechiae, myalgia, arthralgia, and abdominal pain. Blood tests with leukopenia, severe thrombocytopenia, transaminitis, long clotting times. Severe dengue with associated coagulopathy was diagnosed, indicating transfer to ICU. Presents torpid evolution, altered state of consciousness, psychomotor agitation, and aggressiveness. Structural, ischemic-hemorrhagic alterations, bacterial and fungal infections were ruled out. Finally diagnosing dengue encephalitis, confirmed by DENV PCR in CSF. Support measures are provided with favorable evolution. Encephalitis is the most serious neurological complication after dengue virus infection.
Asunto(s)
Humanos , Masculino , Adulto , Púrpura , Trombocitopenia , Dengue/complicaciones , Dengue/diagnóstico , Encefalitis/complicaciones , Dengue Grave/complicaciones , Dengue Grave/diagnóstico , FiebreRESUMEN
Resumen El parvovirus B19 es causante de una variedad de enfermedades exantemáticas durante la infancia y adolescencia, como el eritema infeccioso y el síndrome papular purpúrico en guante y calcetín. Este último es una acrodermatitis aguda, inusual y benigna, que puede asociarse a aftas orales, fiebre y otros síntomas constitucionales. Existen casos atípicos como la púrpura febril en otras localizaciones, sin cumplir la distribución característica en guante y calcetín de forma simétrica o con un mayor componente de eritrodermia. Presentamos el caso de una adolescente de 12 años con un síndrome papular purpúrico de distribución atípica por parvovirus B19.
Abstract Parvovirus B19 is the cause of a variety of exanthematous diseases during childhood and adolescence, such as erythema infectiosum and papular purpuric gloves and socks syndrome. This is an unusual, benign and acute acrodermatitis. Aphtous stomatitis, fever and other systemic symptoms can be associated with the eruption of the purpuric rash. Uncommon patterns such as asymmetrical distribution or erythematous involvement llave recently been described as additional features of PVB19-associated purpuric petechial eruption. This is a case report of a 12-year-old female with an atypical involvement of a papular-purpuric syndrome caused by human parvovirus B19.
Asunto(s)
Humanos , Femenino , Niño , Púrpura/etiología , Parvovirus B19 Humano , Eritema Infeccioso/complicaciones , Eritema Infeccioso/diagnóstico , Dermatosis del Pie/complicaciones , SíndromeRESUMEN
Ethylmalonic encephalopathy (EE) is a severe intoxication disorder caused by mutations in the ETHE1 gene that encodes a mitochondrial sulfur dioxygenase involved in the catabolism of hydrogen sulfide. It is biochemically characterized by tissue accumulation of hydrogen sulfide and its by-product thiosulfate, as well as of ethylmalonic acid due to hydrogen sulfide-induced inhibition of short-chain acyl-CoA dehydrogenase. Patients usually present with early onset severe brain damage associated to encephalopathy, chronic hemorrhagic diarrhea and vascular lesions with petechial purpura and orthostatic acrocyanosis whose pathophysiology is poorly known. Current treatment aims to reduce hydrogen sulfide accumulation, but does not significantly prevent encephalopathy and most fatalities. In this review, we will summarize the present knowledge obtained from human and animal studies showing that disruption of mitochondrial and redox homeostasis may represent relevant pathomechanisms of tissue damage in EE. Mounting evidence show that hydrogen sulfide and ethylmalonic acid markedly disturb critical mitochondrial functions and induce oxidative stress. Novel therapeutic strategies using promising candidate drugs for this devastating disease are also discussed.
Asunto(s)
Lesiones Encefálicas , Púrpura , Animales , Encéfalo/metabolismo , Encefalopatías Metabólicas Innatas , Lesiones Encefálicas/metabolismo , Homeostasis , Humanos , Mitocondrias/metabolismo , Proteínas Mitocondriales/metabolismo , Proteínas de Transporte Nucleocitoplasmático/genética , Proteínas de Transporte Nucleocitoplasmático/metabolismo , Oxidación-Reducción , Púrpura/genética , Púrpura/metabolismo , Púrpura/patologíaAsunto(s)
Infecciones por VIH/complicaciones , Púrpura/patología , Estrongiloidiasis/complicaciones , Estrongiloidiasis/patología , Adulto , Animales , Antibacterianos/uso terapéutico , Antiparasitarios/uso terapéutico , Resultado Fatal , Humanos , Ivermectina/uso terapéutico , Masculino , Meropenem/uso terapéutico , Strongyloides stercoralis , Estrongiloidiasis/parasitologíaRESUMEN
RESUMO As vasculites são um grupo heterogêneo de manifestações clínicas que podem ser idiopáticas ou secundárias a outras desordens. As principais causas de vasculite secundária são as infecções e medicamentos. No entanto, em alguns casos, elas podem ser secundárias a neoplasias, particularmente as neoplasias hematológicas. A vasculite leucocitoclástica é a forma mais comum de vasculite cutânea associada a distúrbios linfoproliferativos². É apresentado caso de homem caucasoide de 53 anos com história de lesões vasculares dolorosas em extremidades de surgimento recente. Realizada investigação complementar, o paciente apresentou exames compatíveis com mieloma de células plasmocitárias e vasculite leucocitoclástica cutânea. Descartando-se os demais diagnósticos diferenciais, foi, então, firmado o diagnóstico de vasculite leucocitoclástica cutânea associada ao mieloma múltiplo. PALAVRAS-CHAVE: Púrpura, vasculite leucocitoclástica secundária, mieloma múltiplo
ABSTRACT Vasculitis is a heterogeneous group of clinical manifestations that can be idiopathic or secondary to other disorders. The main causes of secondary vasculitis are infections and medications. However, in some cases, they can be secondary to neoplasms, particularly hematologic neoplasms. Leukocytoclastic vasculitis is the most common form of cutaneous vasculitis associated with lymphoproliferative disorders². We present the case of a 53-year-old Caucasian male with a history of recent onset of painful vascular lesions in the extremities. After further investigation, the patient presented tests compatible with plasma cell myeloma and cutaneous leukocytoclastic vasculitis. Discarding the other differential diagnoses, the diagnosis of cutaneous leukocytoclastic vasculitis associated with multiple myeloma was then established. KEYWORDS: Purpura, secondary leukocytoclastic vasculitis, multiple myeloma
Asunto(s)
Humanos , Púrpura , Vasculitis Leucocitoclástica Cutánea , Mieloma MúltipleAsunto(s)
Dermatitis/patología , Erupciones Liquenoides/diagnóstico , Enfermedades Linfáticas/patología , Trastornos de la Pigmentación/patología , Seudolinfoma/diagnóstico , Púrpura/patología , Adulto , Antígenos CD7/metabolismo , Biopsia/métodos , Dermoscopía/métodos , Diagnóstico Diferencial , Femenino , Hemosiderina/metabolismo , Humanos , Inmunohistoquímica/métodos , Erupciones Liquenoides/patología , Micosis Fungoide/diagnóstico , Micosis Fungoide/metabolismo , Patología Clínica , Linfocitos T/metabolismoRESUMEN
ABSTRACT CONTEXT: Various skin manifestations have been reported in coronavirus disease. It may be difficult to determine the etiology of these lesions in view of the increased frequency of handwashing during the pandemic, along with occurrences of irritant contact dermatitis and allergic contact dermatitis due to disinfectant use; usage of herbal medicine and supplements to strengthen the immune system; and urticarial or maculopapular drug eruptions due to COVID-19 treatment. The variety of associated skin manifestations seen with COVID-19 makes it challenging to identify virus-specific skin manifestations. Petechiae, purpura, acrocyanosis and necrotic and non-necrotic purpura, which can be considered as manifestations of vascular involvement on the skin, have been reported. CASE REPORT: Here, we report a case of eruptive cherry angiomas, which was thought to have developed due to COVID-19, with a papulovesicular rash on distal extremities that progressed over time to reticular purpura. CONCLUSION: The case presented had a papulovesicular rash at the onset, which evolved to retiform purpura, and eruptive cherry angiomas were observed. It should be kept in mind that dermatological signs may vary in patients with COVID-19.
Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Púrpura/virología , Piel/virología , Enfermedades Cutáneas Virales/virología , Exantema/virología , COVID-19/complicaciones , COVID-19/virología , Hemangioma/virología , Piel/efectos de los fármacos , Piel/patología , Resultado del Tratamiento , Enfermedades Cutáneas Virales/diagnóstico , Enfermedades Cutáneas Virales/terapia , Prueba de COVID-19 , SARS-CoV-2 , COVID-19/tratamiento farmacológico , COVID-19/terapiaRESUMEN
CONTEXT: Various skin manifestations have been reported in coronavirus disease. It may be difficult to determine the etiology of these lesions in view of the increased frequency of handwashing during the pandemic, along with occurrences of irritant contact dermatitis and allergic contact dermatitis due to disinfectant use; usage of herbal medicine and supplements to strengthen the immune system; and urticarial or maculopapular drug eruptions due to COVID-19 treatment. The variety of associated skin manifestations seen with COVID-19 makes it challenging to identify virus-specific skin manifestations. Petechiae, purpura, acrocyanosis and necrotic and non-necrotic purpura, which can be considered as manifestations of vascular involvement on the skin, have been reported. CASE REPORT: Here, we report a case of eruptive cherry angiomas, which was thought to have developed due to COVID-19, with a papulovesicular rash on distal extremities that progressed over time to reticular purpura. CONCLUSION: The case presented had a papulovesicular rash at the onset, which evolved to retiform purpura, and eruptive cherry angiomas were observed. It should be kept in mind that dermatological signs may vary in patients with COVID-19.